Liven Pharmaceuticals Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	May '25 May 13, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2015 - 2019
Market Capitalization	5,436	110	185	152	303	133	Upgrade
Market Cap Growth	6809.90%	-40.46%	21.91%	-49.80%	127.48%	83.37%	Upgrade
Enterprise Value	5,474	349	423	387	535	359	Upgrade
Last Close Price	58.43	9.11	15.30	12.55	25.00	10.99	Upgrade
PB Ratio	6.07	-0.82	-1.51	-1.38	-3.16	-1.63	Upgrade
P/TBV Ratio	6.33	-	-	-	-	-	Upgrade
EV/EBITDA Ratio	243.96	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.04	-1.78	-1.94	-2.13	-2.43	-2.76	Upgrade
Debt / EBITDA Ratio	1.70	-	-	-	-	-	Upgrade
Quick Ratio	1.76	0	0	0	0	0	Upgrade
Current Ratio	3.76	0	0	0	0.00	0	Upgrade
Return on Equity (ROE)	28.18%	-	-	-	-	-	Upgrade
Return on Assets (ROA)	-0.04%	-6.86%	-6.89%	-7.20%	-6.80%	-6.82%	Upgrade
Return on Capital (ROIC)	-0.04%	-7.84%	-7.93%	-8.35%	-8.08%	-8.12%	Upgrade
Earnings Yield	1.98%	-10.12%	-6.65%	-9.39%	-4.83%	-12.70%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.